Table: Delta-Fly Pharma - 9-MTH parent results

Delta-Fly Pharma

12/02/2021 07:00

Feb 12 (Reuters)- 
             Delta-Fly Pharma, Inc. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended        Year to   
                Dec 31, 2020        Dec 31, 2019       Mar 31, 2021  
                   LATEST             YEAR-AGO            LATEST     
                   RESULTS             RESULTS           FORECAST    
  Sales            100 mln                               300 mln     
                                                       (+200.0 pct)  
  Operating     loss 770 mln          loss 1.22        loss 850 mln  
  Recurring     loss 770 mln          loss 1.23        loss 850 mln  
  Net           loss 773 mln          loss 1.23        loss 850 mln  
  EPS          loss 171.63 yen     loss 276.70 yen   loss 188.70 yen 
  Ann Div                                NIL               NIL       
  -Q2 div            NIL                 NIL                         
  -Q4 div                                NIL               NIL       
  
  NOTE - Delta-Fly Pharma, Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4598.T